(Q40231516)

18 September 2017

title

Cytoplasmic localization of p63 is associated with poor patient survival in lung adenocarcinoma (English)

1 reference

18 September 2017

1 reference

Narahashi T

1

1 reference

18 September 2017

Niki T

2

1 reference

18 September 2017

Wang T

3

1 reference

18 September 2017

Goto A

4

1 reference

18 September 2017

Matsubara D

5

1 reference

18 September 2017

Funata N

6

1 reference

18 September 2017

Fukayama M

7

1 reference

18 September 2017

publication date

1 October 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

49

1 reference

18 September 2017

issue

4

1 reference

18 September 2017

page(s)

349-357

1 reference

A statistical study of lung cancer in the annual of pathological autopsy cases in Japan, from 1958 to 1997, with reference to time trends of lung cancer in the world

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

Loss of TSLC1 expression in lung adenocarcinoma: relationships with histological subtypes, sex and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

Differential expression of p63 isoforms in normal tissues and neoplastic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

p63 immunoreactivity in lung cancer: yet another player in the development of squamous cell carcinomas?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

A lack of prognostic significance regarding DeltaNp63 immunoreactivity in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

Frequent co-localization of Cox-2 and laminin-5 gamma2 chain at the invasive front of early-stage lung adenocarcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

P63 expression in lung carcinoma: a tissue microarray study of 408 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

The protein stability and transcriptional activity of p63alpha are regulated by SUMO-1 conjugation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

Parc: a cytoplasmic anchor for p53.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

p73 and p63 protein stability: the way to regulate function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

p53 associates with and targets Delta Np63 into a protein degradation pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2559.2006.02507.X

10.1111/J.1365-2559.2006.02507.X

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference